Genetics of Parkinson's disease

Clinical Genetics

Volumn 54, Issue 4, 1998, Pages 259-265

  Gasser, Thomas ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME 2P; CHROMOSOME 4; CHROMOSOME 4Q; CLINICAL GENETICS; DEGENERATIVE DISEASE; DOMINANT INHERITANCE; FAMILIAL DISEASE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; LEWY BODY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TWINS;

CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 4; CHROMOSOMES, HUMAN, PAIR 6; HUMANS; LIGASES; PARKINSON DISEASE; PROTEINS; UBIQUITIN-PROTEIN LIGASES;

PARKINSONIA;

EID: 0031727163     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.1998.5440401.x     Document Type: Review

References (57)

1. Bonifati V, Fabrizio E, Vanacore N, De Mari M, Meco G. Familial Parkinson's disease: a clinical genetic analysis. Can J Neurol Sci 1995: 22: 272-279.
2. De Michele G, Filla A, Volpe G, De Marco V, Gogliettino A et al. Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy. Mov Disord 1996: 11: 17-23.
3. Lazzarini AM, Myers RH, Zimmerman Jr. TR, Mark MH, Golbe LI et al. A clinical genetic study of Parkinson's disease: evidence for dominant transmission. Neurology 1994: 44: 499-506.
4. Marder K, Tang MX, Mejia H, Alfaro B, Cote L et al. Risk of Parkinson's disease among first-degree relatives: a community-based study. Neurology 1996: 47: 155-160.
5. Payami H, Larsen K, Bernard S, Nutt J. Increased risk of Parkinson's disease in parents and siblings of patients. Ann Neurol 1994: 36: 659-661.
6. Vieregge P, Heberlein I. Increased risk of Parkinson's disease in relatives of patients. Ann Neurol 1995: 37: 685.
7. Farrer LA, O'Sullivan DM, Cupples LA, Growdon JH, Myers RH. Assessment of genetic risk for Alzheimer's disease among first-degree relatives. Ann Neurol 1989: 25: 485-493.
8. Duvoisin RC, Eldridge R, Williams A, Nutt J, Calne D. Twin study of Parkinson disease. Neurology 1981: 31: 77-80.
9. Marttila RJ, Kaprio J, Koskenvuo M, Rinne UK. Parkinson's disease in a nationwide twin cohort. Neurology 1988: 38: 1217-1219.
10. Ward CD, Duvoisin RC, Ince SE, Nutt JD, Eldridge R et al. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology 1983: 33: 815-824.
11. Holthoff VA, Vieregge P, Kessler J, Pietrzyk U, Herholz K et al. Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits. Ann Neurol 1994: 36: 176-182.
12. Burn DJ, Mark MH, Playford ED, Maraganore DM, Zimmerman Jr. TR et al. Parkinson's disease in twins studied with 18F-dopa and positron emission tomography. Neurology 1992: 42: 1894-1900.
13. Piccini P, Burn DJ, Ceravolo R, Brooks DJ. F-dopa PET studies in discordant twins with Parkinson's disease: a follow-up. J Neurol 1998: 245: 364 (Abstract).
14. Piccini P, Morrish PK, Turjanski N, Sawle GV, Burn DJ et al. Dopaminergic function in familial Parkinson's disease: a clinical and 18F-dopa positron emission tomography study. Ann Neurol 1997: 41: 222-229.
15. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991: 114: 2283-2301.
16. Markopoulou K, Wszolek ZK, Pfeiffer RF. A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation. Ann Neurol 1995: 38: 373-378.
17. Wszolek ZK, Pfeiffer B, Fulgham JR, Parisi JE, Thompson BM et al. Western Nebraska family (family D) with autosomal dominant parkinsonism. Neurology 1995: 45: 502-505.
18. Wszolek ZK, Cordes M, Calne DB, Munter MD, Cordes I et al. Hereditary Parkinson disease: report of 3 families with dominant autosomal inheritance. Nervenarzt 1993: 64: 331-335.
19. Golbe LI, Di Iorio G, Bonavita V, Miller DC, Duvoisin RC. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol 1990: 27: 276-282.
20. Ishikawa A, Tsuji S. Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism. Neurology 1996: 47: 160-166.
21. Wszolek ZK, Pfeiffer RF, Bhatt MH, Schelper RL, Cordes M et al. Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration. Ann Neurol 1992: 32: 312-320.
22. Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE et al. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 1996: 274: 1197-1199.
23. Di Rocco A, Molinari SP, Kollmeier B, Yahr MD. Parkinson's disease: progression and mortality in the L-DOPA era. Adv Neurol 1996: 69: 3-11.
24. Golbe LI, Di Iorio G, Sanges G, Lazzarini A, LaSala S et al. Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Ann Neurol 1996: 40: 767-775.
25. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997: 276: 2045-2047.
26. Gasser T, Müller-Myhsok B, Wszolek Z, Dürr A, Vaughan JR et al. Genetic complexity and Parkinson's disease. Science 1997: 277: 388-389.
27. Wszolek Z, Vieregge P, Uitti RJ, Gasser T, Yasuhara O et al. German-Canadian family (Family A) with parkinsonism, amyotrophy, and dementia-longitudinal observations. Parkinsonism Related Disord 1997: 3: 125-139.
28. Denson MA, Wszolek ZK, Pfeifer RF, Wszolek EK, Puschall TM et al. Familial parkinsonism, dementia, and Lewy-body disease: study of family G. Ann Neurol 1997: 42: 638-643.
29. Mazzetti P, Le Guern E, Bonnet AM, Vidailhet M, Brice A et al. Familial Parkinson's disease and polymorphism at the CYP2D6 locus. J Neurol Neurosurg Psychiatry 1994: 57: 871-872.
30. Sawle GV, Wroe SJ, Lees AJ, Brooks DJ, Frackowiak RS. The identification of presymptomatic parkinsonism: clinical and [18F]dopa positron emission tomography studies in an Irish kindred. Ann Neurol 1992: 32: 609-617.
31. Scott WK, Stajich JM, Yamaoka L-H, Speer MC, Vance JM et al. Genetic complexity in Parkinson's disease. Science 1997: 277: 387-388.
32. Vaughan JR, Durr A, Gasser T, Bonifati V, De Michele G et al. The α-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. Neurology 1998 (in press)
33. Vaughan JR, Farrer M, Wszolek EK, Gasser T, Durr A et al. Sequencing of the alpha-synuclein gene in a large series of families with familial Parkinson's disease fails to reveal any further mutations. Hum Mol Genet 1998: 7: 751-753.
34. Krüger R, Kuhn W, Müller T, Woitalla D, Graeber M et al. Ala39Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 1998: 18: 106-108.
35. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R et al. Alpha-synuclein in Lewy bodies. Nature 1997: 388: 839-840.
36. Golbe LI. Young-onset Parkinson's disease: a clinical review. Neurology 1991: 41: 168-173.
37. Ishikawa A, Tsuji S. Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism. Neurology 1996: 47: 160-166.
38. Ichinose H, Ohye T, Takahashi E, Seki N, Hori T et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994: 8: 236 242.
39. Nygaard TG, Trugman JM, de Yebenes JG, Fahn S. Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology 1990: 40: 66-69.
40. Matsumine H, Saito M, Shimoda-Matsubayashi S, Tanaka H, Ishikawa A et al. Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. Am J Hum Genet 1997: 60: 588-596.
41. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998: 392: 605-608.
42. Gasser T, Müller-Myhsok B, Wszolek ZK, Oehlmann R, Calne DB et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 1998: 18: 262-265.
43. Smith CA, Gough AC, Leigh PN, Summers BA, Harding AE, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease [published erratum appears in Lancet 1992 Jul 4: 340 (8810): 64] [see comments]. Lancet 1992: 339: 1375-1377.
44. Armstrong M, Daly AK, Cholerton S, Bateman DN, Idle JR. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 1992: 339: 1017-1018.
45. Kondo I, Kanazawa I. Debrisoquine hydroxylase and Parkinson's disease. Adv Neurol 1993: 60: 338-342.
46. Lucotte G, Turpin JC, Gerard N, Panserat S, Krishnamoorthy R. Mutations frequencies of the cytochrome Cyp2D6 gene in Parkinson disease patients and in families. Am J Med Genet 1996: 67: 361-365.
47. Kurth MC, Kurth JH. Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease. Am J Med Genet 1993: 48: 166-168.
48. Gasser T, Müller-Myhsok B, Supala A, Zimmer R, Wieditz G et al. The CYP2D6B-allele is not over-represented in a population of German patients with idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1996: 61: 518-520.
49. Diederich N, Hilger C, Goetz CG, Keipes M, Hentges F et al. Genetic variability of the CYP2D6 gene is not a risk factor for sporadic Parkinson's disease. Ann Neurol 1996: 40: 463-465.
50. Ray Chaudhuri K, Smith C, Gough AC, Novak N, Chamoun V et al. Debrisoquine hydroxylase gene polymorphism in Parkinson's disease and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1995: 58: 109.
51. Plante Bordeneuve V, Davis MB, Maraganore DM, Marsden CD, Harding AE. Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease. J Neurol Neurosurg Psychiatry 1994: 57: 911-913.
52. Wilhelmsen KC, Mirel D, Marder K, Bernstein M, Naini A et al. Is there a genetic susceptibility locus for Parkinson's disease on chromosome 22q13? Ann Neurol 1997: 41: 813-817.
53. Hotamisligil GS, Girmen AS, Fink JS, Tivol E, Shalish C et al. Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease. Mov Disord 1994: 9: 305-310.
54. Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD. Association of a monoamine oxidase B allele with Parkinson's disease. Ann Neurol 1993: 33: 368-372.
55. Plante Bordeneuve V, Taussig D, Thomas F, Said G, Wood NW et al. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele. Neurology 1997: 48: 1589-1593.
56. Bandmann O, Vaughan JR, Holmans P, Marsden CD, Wood N. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet 1998: 350: 1136-1139.
57. Nicholl DJ, Bennett P, Bonifati V, Colosimo C, Fabbrini G et al. A study of 5 candidate genes in Parkinson's disease and related neurodegenerative disorders. J Neurol 1998: 245: 363 (Abstract).